Cargando…
Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase
Viral replication of thymidine kinase deleted (tk(−)) vaccinia virus (VV) is attenuated in resting normal cells, enabling cancer selectivity, however, replication potency of VV-tk(−) appears to be diminished in cancer cells. Previously, we found that wild-type herpes simplex virus (HSV)-tk (HSV-tk)...
Autores principales: | Islam, S. M. Bakhtiar UL, Hong, Young Mi, Ornella, Mefotse saha Cyrelle, Ngabire, Daniel, Jang, Hyunjung, Cho, Euna, Kim, Eung-Kyun, Hale, Jessye Jin Joo, Kim, Cy Hyun, Ahn, Soon Cheol, Cho, Mong, Hwang, Tae-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650665/ https://www.ncbi.nlm.nih.gov/pubmed/33081279 http://dx.doi.org/10.3390/biomedicines8100426 |
Ejemplares similares
-
Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
por: Islam, S. M. Bakhtiar Ul, et al.
Publicado: (2020) -
Effect of aldosterone on the amplification of oncolytic vaccinia virus in human cancer lines
por: Lee, Hyun Ju, et al.
Publicado: (2011) -
Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes
por: Cho, Euna, et al.
Publicado: (2020) -
Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017) -
Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes
por: Ornella, Mefotse Saha Cyrelle, et al.
Publicado: (2023)